Data / Form D filings / TP Therapeutics, Inc.
TP Therapeutics, Inc.: Form D filings
TP Therapeutics, Inc., a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2014 and 2018. The latest, on October 30, 2018, reports $80 million sold of a $80 million offering to 16 investors.
Find out what TP Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10628 SCIENCE CENTER DRIVE, SUITE 225, San Diego, CA, 92121
- Phone
- (858) 926-5251
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1595893
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2018 | New notice | $80,000,016 | $80,000,016 | $0 | 16 | Oct 18, 2018 | sec.gov |
| May 25, 2017 | New notice | $45,000,017 | $45,000,017 | $0 | 13 | May 17, 2017 | sec.gov |
| Jan 6, 2014 | New notice | $3,500,000 | $1,429,999 | $2,070,001 | 8 | Dec 27, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert J. Adelman | Director | |
| Hongbo Maria Lu | Director | |
| Simeon Maria George | Director | |
| Lewis J. Shuster | Director | |
| Brett J. Zbar | Director | |
| Carl Maria Gordon | Director | |
| Athena Maria Countouriotis | Executive Officer, Director | |
| Sheila K. Gujrathi | Director | |
| Yishan Li | Director | |
| Jingrong Cui | Executive Officer, Director | |
| Kenneth Fong | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Oct 29, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TP Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.